Model Care
The Canadian pharmaceutical landscape is undergoing a “biologic revolution,” and there’s no end in sight. How will pharmacy care models adapt? Biologic or “biotech” drugs are continuing to increase, both in terms of utilization and as a percentage of overall pharmacy expenditures. Pharmacy benefit managers such as Caremark and ESI report that in the U.S., […]
- November 1, 2007 September 13, 2019
- 00:00